Abstract
Surgical resection remains the treatment of choice for liver malignancies, however a variety of minimally invasive therapeutic techniques have been developed since patients are not always eligible for surgical approach. The minimally invasive methods include transcatheter arterial chemoembolization, percutaneous ethanol injection, radiofrequency ablation, microwave ablation, cryotherapy and interstitial laser coagulation therapy. In the current article, the MR appearance of both successful and incomplete focal therapies, in the setting of liver malignancy, was reviewed. Although some therapies may exhibit similar MR findings post intervention, peculiar MR features can be appreciated in some procedures.
Keywords: MR imaging, liver tumors, minimally invasive therapeutic methods
Current Cancer Therapy Reviews
Title: MRI Evaluation of Treatment Response for Local Therapies for Malignant Liver Lesions
Volume: 4 Issue: 4
Author(s): Polytimi Leonardou, Siobhan Kierans, Larissa Braga, Mohamed Elazzazzi and Richard C. Semelka
Affiliation:
Keywords: MR imaging, liver tumors, minimally invasive therapeutic methods
Abstract: Surgical resection remains the treatment of choice for liver malignancies, however a variety of minimally invasive therapeutic techniques have been developed since patients are not always eligible for surgical approach. The minimally invasive methods include transcatheter arterial chemoembolization, percutaneous ethanol injection, radiofrequency ablation, microwave ablation, cryotherapy and interstitial laser coagulation therapy. In the current article, the MR appearance of both successful and incomplete focal therapies, in the setting of liver malignancy, was reviewed. Although some therapies may exhibit similar MR findings post intervention, peculiar MR features can be appreciated in some procedures.
Export Options
About this article
Cite this article as:
Leonardou Polytimi, Kierans Siobhan, Braga Larissa, Elazzazzi Mohamed and Semelka C. Richard, MRI Evaluation of Treatment Response for Local Therapies for Malignant Liver Lesions, Current Cancer Therapy Reviews 2008; 4 (4) . https://dx.doi.org/10.2174/157339408786413344
DOI https://dx.doi.org/10.2174/157339408786413344 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
How Insulin Receptor Substrate Proteins Regulate the Metabolic Capacity of the Liver - Implications for Health and Disease
Current Medicinal Chemistry Therapeutic Potential of Natural Products in Parkinson’s Disease
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Measurement of Vitamin K Metabolites in Neonatal Faecal Matter by HPLC with Electrochemical Detection
Current Chromatography Heparin Derivatives as Angiogenesis Inhibitors
Current Pharmaceutical Design Prospective Role of Polyphenolic Compounds in the Treatment of Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets Silencing the Brain May be Better than Stimulating it. The GABA Effect
Current Pharmaceutical Design Nitric Oxide Production and Signaling in Inflammation
Current Drug Targets - Inflammation & Allergy Regulation of Neurogenesis and Gliogenesis by Stress and Antidepressant Treatment
CNS & Neurological Disorders - Drug Targets Exploiting Cyclooxygenase-(in)Dependent Properties of COX-2 Inhibitors for Malignant Glioma Therapy
Anti-Cancer Agents in Medicinal Chemistry Can Statin be a Novel Pharmacophore for Antidiabetic Activity?
Mini-Reviews in Medicinal Chemistry PET and SPECT Imaging for the Acceleration of Anti-Cancer Drug Development
Current Drug Targets Potassium Channels as Targets for the Management of Pain
Central Nervous System Agents in Medicinal Chemistry Recent Patents Related to Phosphorylation Signaling Pathway on Cancer
Recent Patents on DNA & Gene Sequences Recent Advances in Methods of Puerarin Biotransformation
Mini-Reviews in Medicinal Chemistry The Pharmacology of Cyclic Nucleotide-Gated Channels: Emerging from the Darkness
Current Pharmaceutical Design Recent Advances in c-Jun N-Terminal Kinase (JNK) Inhibitors
Current Medicinal Chemistry Antiphospholipid Syndrome as a Neurological Disease
Current Rheumatology Reviews Are Circulating Monocytes as Microglia Orthologues Appropriate Biomarker Targets for Neuronal Diseases? (Supplementry Table)
Central Nervous System Agents in Medicinal Chemistry Zinc-Permeable Ion Channels: Effects on Intracellular Zinc Dynamics and Potential Physiological/Pathophysiological Significance
Current Medicinal Chemistry Use of Diverse Chemometric and Validation Methods to Accurately Predict Human Urotensin-II Receptor Antagonist Activity
Current Computer-Aided Drug Design